STADA Health Report 2019: Half of Europeans are ready for Dr Robot and treatments via webcam

  • 56 percent of Europeans would undergo surgery with “Dr Robot”
  • 54 percent would receive treatment from their GP via webcam
  • 80 percent would take a gene test but only one quarter knows what a gene test can detect
  • Overall, men are more open to medical trends and new health technologies than women
  • 53 percent of Europeans feel optimistic about the future of health

56 percent of Europeans would undergo surgery with “Dr Robot” and 54 percent would receive treatment from their GP via webcam. These are two key findings of the STADA Health Report 2019. The study stands under the sign of the Future of Health and includes 18,000 respondents from nine European countries. The report also shows that 4 out of 5 Europeans would take a gene test and 38 percent would be willing to get a biosensor implant. Looking at the results in detail, interesting disparities come to light between the individual countries. Who is ready for the future of health?

“STADA is excited to share the results of our 5th annual Health Report. The insights will help us to understand trends and perceptions much better to serve patients and healthcare professionals even stronger in the future. This will strengthen STADA’s position as a leading go-to partner in European Healthcare,” says Peter Goldschmidt, CEO STADA Arzneimittel AG.

Around 2,000 people each from Belgium, France, Germany, Italy, Poland, Russia, Serbia, Spain and the UK between the ages of 18 to 99 shared their opinion on future health matters. The survey was conducted by market research institute Kantar Health on behalf of STADA Arzneimittel AG.

Further information: www.yourhealth.stada.

Contact:
STADA Arzneimittel AG
Phone: +49 (0) 6101 603-165
E-mail: press@stada.de

Source: RealWire

user

Recent Posts

Sona Nanotech Updates on Dalhousie Efficacy Study and New NCL Results

Halifax, Nova Scotia--(Newsfile Corp. - March 25, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB:…

13 mins ago

GE HealthCare Announces the FDA Clearance of nCommand Lite by IONIC Health

GE HealthCare to exclusively distribute nCommand Lite by IONIC Health for multi-vendor, multi-modality remote operations…

1 hour ago

Inogen To Present at 23rd Annual Needham Virtual Healthcare Conference

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for…

1 hour ago

Politan Nominates Two Independent Candidates for Masimo Board

Supports Strategic Review of Consumer Business, But Has Serious Concerns Given Masimo’s Broken Governance and…

1 hour ago

Akanda Corp. Announces Pricing of Underwritten Public Offering

London, United Kingdom--(Newsfile Corp. - March 25, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or…

1 hour ago